Life Sciences - Spin-off Transactions

more+
less-
more+
less-
Explore:  Life Sciences SEC Spinoffs

Spin-off transactions can be beneficial, but they are complicated, time-consuming and expensive, and can trigger lawsuits and other problems for the parent company if not carefully planned and implemented. This Client Alert discusses briefly some key regulatory and business matters to consider in contemplation of a possible spin-off transaction.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Life Sciences, SEC, Spinoffs

Published In: Business Organization Updates, Securities Updates, Tax Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© TroyGould PC | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »